SCHEMBL4988053

SCHEMBL4988053

Cn1cc(CN2CCc3c(N)ncnc3C2)c2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
TSHR P16473 1/20 0.58
LMNA P02545 2/20 0.47
GLA P06280 1/20 0.47
PDE2A O00408 1/20 0.42
LIMK1 P53667 1/20 0.41
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
PEX14 O75381 1/20 0.41
GPR84 Q9NQS5 1/20 0.41
HTR2A P28223 1/20 0.40
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 1/20 0.39
DHFR P00374 1/20 0.39
CSF1R P07333 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13532626 0.77 ALDH1A1 (0.47) ALDH1A1TSHRLMNAGLAPDE2A
SCHEMBL4988948 0.77 LIMK1 (0.43) ALDH1A1TSHRLMNALIMK1DHFR
SCHEMBL4989327 0.77 BCHE (0.53) ALDH1A1TSHRLMNADRD2DRD4
SCHEMBL4982816 0.76 BCHE (0.46) ALDH1A1LIMK1DHFR
SCHEMBL4982960 0.76 LIMK1 (0.61) ALDH1A1GLALIMK1DHFR
SCHEMBL4989437 0.76 LIMK1 (0.40) ALDH1A1LIMK1DRD2DRD4DRD3
SCHEMBL14272474 0.76 TSHR (0.48) ALDH1A1TSHRLMNAGLADRD2
SCHEMBL6970868 0.72 ALDH1A1 (0.76) ALDH1A1TSHRLMNAGLADRD2
SCHEMBL4985387 0.72 DRD2 (0.43) LMNALIMK1DRD2DRD4DRD3
SCHEMBL4989371 0.72 LIMK1 (0.47) ALDH1A1LMNALIMK1DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed
US-7297700-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2007-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 ALDH1A1 3640/4885TSHR 3850/4885LMNA 1911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.